Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in Bronchial Dysplasia
NCT00175747Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lung cancer comparing Budesonide with Placebo (2 arms). Primary endpoint: Rate of progression of bronchial dysplasia at 6 months. Started Jan 2000; status: completed.
02
Drugs
budesonide
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00175747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175747.